Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07763080

Reverse Fly Exercise On Supraspinatus Tendinitis In Patients Receiving Aromatase Inhibitors Therapy After Mastectomy

Reverse Fly Exercise On Supraspinatus Tendinitis In Patients Receiving Aromatase Inhibitors Therapy After Mastectomy

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Mastectomy Aromatase Inhibitors Therapy

Age range

50 year–70 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

National Cancer Institute(NCI)

Cairo, Egypt

Location status: Recruiting

About this study

40 female patients who have mastectomy and receiving aromatase inhibitor therapy will participate in this study. Their ages will be ranged from 50 to 70 years. The participants will be selected from (national cancer institution

Design of the study:

In this study the patients will be randomly assigned into two equal groups Group A (Study group): This group will include 20 patients who will receive after 3:6 weeks from starting aromatase inhibitor the reverse fly exercise , in additions Traditional treatment for tendonitis post mastectomy and their medical treatment. (physiotherapeutic treatments 3 times a week for 8 weeks , including , (pendulum ex , soft tissue release , stretching ex., strengthening ex. and ROM ex.) and their medical treatment.

Group B (Control group):

This group includes 20 patients who will receive the traditional physical therapy program (pendulum ex , soft tissue release, stretching ex., strengthening ex. and ROM ex.) and their medical treatment ,3 times a week for 8 weeks.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age range between 50:70 years.
  • Female patients participate in the study.
  • All patients with unilateral mastectomy.
  • Patients who receiving aromatase inhibitors treatment.
  • All patients will enroll in this study with have their informed consent.

Exclusion criteria

  • Patients have Metastases
  • Patients with Lymphedema
  • Patients with Rheumatoid arthritis
  • Patients have Neurological deficits (stroke, Parkinsonism)
  • Patients with Psychological disorders

Treatment and study plan

Reverse fly excercise

Other

The procedure Stand with feet shoulder width apart while holding a dumbbell in each hand Flex the hips and knees slightly leaning the trunk forward while maintaining a neutral spine Allow the arms to hang perpendicular to the floor with elbows slightly flexed Horizontally abduct the shoulders by lifting the arms laterally until they are level with the shoulders Retract the scapulae at the top of the movement without elevating the shoulders Lower the arms slowly and with control back to the starting position Repeat for the desired number of repetitions

Control Group

Other

This group includes 20 patients who will receive the traditional physical therapy program (pendulum ex , soft tissue release, stretching ex., strengthening ex. and ROM ex.) and their medical treatment ,3 times a week for 8 weeks. 1.2 Criteria for the patient selection:

Primary outcomes

  1. Supraspinatus Tendon Thickness

    Time frame: Before 1st physical therapy session And after 8 weeks of regular 3 session per week of physical therapy

    Using Dynamic ultrasonography for measuring

  2. Functional ability

    Time frame: Before 1st physical therapy session And after 8 weeks of regular 3 sessions/week of physical therapy

    By Quik DASH Questionnaire

Study contacts

Contact information is provided by the study sponsor or research team.

Nourhan Ahmed Mahmoud Souliman, Master degree

CONTACT

[email protected]

+201112852496

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Aug 13, 2026
Registry last updated
Aug 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.